期刊文献+

载脂蛋白E和补体C4b1在人胰腺癌组织中的表达及意义 被引量:2

Apolipoprotein E and complement C4b1 expressions and its significance in human pancreatic carcinoma
原文传递
导出
摘要 目的 检测载脂蛋白E(ApoE)和补体C4b1在人胰腺癌组织中的表达,探讨其意义.方法 应用免疫组化法检测38例胰腺癌和相应癌旁正常胰腺组织ApoE、C4b1蛋白表达;应用RT-PCR法检测20例胰腺癌和相应癌旁正常胰腺组织ApoE、C4b1 mRNA表达.分析ApoE、C4b1的表达与胰腺癌生物特征的相关性.结果 胰腺癌组织ApoE、C4b1蛋白表达阳性率分别为86.8%(33/38)和76.3%(29/38),显著高于癌旁正常胰腺组织的42.1%(16/38)和26.3%(10/38)(P值均<0.01);有淋巴结转移的胰腺癌组织ApoE、C4b1蛋白表达阳性率分别为78.3%(18/23)和73.9%(17/23),明显高于无转移者的33.3%(5/15)和40.0%(6/15)(P值均<0.05).胰腺癌ApoE、C4b1 mRNA表达量分别为4.83±0.65、7.94±0.95,明显高于癌旁正常胰腺组织的1.78±0.74、1.22±0.57(P值均<0.01);有淋巴结转移的胰腺癌组织ApoE、C4b1 mRNA的表达量为5.05±0.71、8.24±1.07,显著高于无转移者的4.42±0.25、7.39±0.15(P值均<0.05).结论 ApoE、C4b1在胰腺癌组织中高表达,并与胰腺癌淋巴结转移相关. Objective To investigate the expression of apolipoprotein E (ApoE) and complement C4b1 in pancreatic carcinoma and study its significance. Methods Immunohistochemistry was used to detect the expression of ApoE and C4b1 protein in 38 cases of pancreatic carcinoma tissues and adjacent normal pancreatic tissues, and RT-PCR was used to detect the expression of ApoE and C4b1 mRNA in 20 cases of pancreatic carcinoma tissues and adjancent normal pancreatic tissues. The relevance of ApoE and C4b1 expressions to the biological features of pancreatic carcinoma were analyzed. Results The positive rates of ApoE and C4b1 expressions are 86.8% (33/38) and 76.3% (29/38) in pancreatic carcinoma, respectively,which were significantly higher than those in normal pancreatic tissues [42.1% (16/38) and 26.3% ( 10/38 ),P < 0.01]. The positive rates of ApoE and C4b1 expressions [78.3% ( 18/23 ) and 73.9% ( 17/23 )] in patients with metastasis were significantly higher than in those without metastasis [(33.3% (5/15) and 40.0%(6/15), P < 0.05). Significantly higher expressions of ApoE and C4b1 mRNA were noted in pancreatic carcinoma(4.83 ± 0.65 and 7.94 ± 0. 95 ) than those in the normal pancreatic tissue ( 1.78 ± 0.74and 1.22 ±0.57, P < 0.01 ), and patients with metastasis showed significantly higher expression of ApoE and C4b1 mRNA (5.05 ±0.71 and 8.24 ± 1.07) than those without metastasis (4.42 ±0.25 and 7.39 ±0.15,P < 0.05). Conclusions ApoE and C4b1 were highly expressed in pancreatic cancer, and may be closely related with lymph node metastasis.
出处 《中华胰腺病杂志》 CAS 2011年第2期89-91,共3页 Chinese Journal of Pancreatology
基金 安徽省科技攻关计划项目(07010302203)
关键词 胰腺肿瘤 载脂蛋白E类 补体C4b 转移 Pancreatic neoplasms Apolipoproteins E Complement C4b Metastasis
  • 相关文献

参考文献1

二级参考文献6

  • 1Sirica AE, Lai GH, Endo K, et al. Cyclcoxygenaso-2 and ERBB-2 in eholangicoarcinoma: potential therapeutic targets [ J ]. Semln Liver Dis, 2002,22 ( 3 ) : 303-313.
  • 2Ohashi H, Takagi H, Oh H, et al. Phosphatidylinositol 3-kinase/ Akt regulates angiotensin II-induced inhibition of apoptosis in microvascular endothelial ceils by governing survivin expression and suppression of caspase-3 activity [ J ]. Circ Res, 2004,94 (6) : 785- 793.
  • 3Sawaoka H, Tsuji S, Tsujii M, et al. Cyelooxygenase inhibitors suppress ansiogenesis and reduce tumor gowth in vivo [ J]. Lab Invest,1999,79(12) : 1469-1477.
  • 4$onoshita M, Takaku K, Sasaki N, et al. Acceleration of intestinal polyposis through prostaglandin receptor EP2 in Apc ( Delta 716 ) knockout mice [J]. Nat Med, 2001,7(9) :1048-1051.
  • 5O'Connor DS, Schechner JS, Adida C, et al. Control of apoptosis during Angiogenesis by survivin expression in endothelial cells [ J].Am J Pathol, 2000,156 ( 2 ) : 393-398.
  • 6Yu J, Leung WK, Ebert MP, et al, Increased expression of Survivin in gastric cancer patients and in first degree relatives [ J ]. Br J Cancer, 2002,87( 1 ) :91-97.

共引文献4

同被引文献27

  • 1Shen, Yong-Mei,Yang, Xiao-Chun,Song, Miao-Li,Qin, Chen-Hao,Yang, Chen,Sun, Yi-Hui.Growth inhibition induced by short hairpin RNA to silence survivin gene in human pancreatic cancer cells[J].Hepatobiliary & Pancreatic Diseases International,2010,9(1):69-77. 被引量:18
  • 2吕楠,张宏艳,刘端祺.胰腺癌流行病学研究进展[J].中国肿瘤临床,2007,34(23):1368-1372. 被引量:24
  • 3Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013 [J]. CA Cancer J Clin, 2013, 63 (1): 11- 30.
  • 4Marchevsky AM, Netson V, Martin SE, et al. Telecytology of fine-needle aspiration biopsies of the pancreas: a study of well-differentiated adenocarcinoma and chronic panereatits with atypical repair changes [J]. Diagen CvtoDathol, 2003, 28 (3): 147-152.
  • 5Goonetilleke KS, Siriwardena AK. Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer [J]. Eur J Surg Oncol, 2007, 33: 266-270.
  • 6ChenY, GaoSG, ChenJM, et al. Serum CA242, CA199, CA125, CEA, and TSGF are biomarkers for the eficaey and prognosis of cryoablation in pancreatic cancer patients [J]. Cell Biochem Biophys, 2015, 71: 1287-1291.
  • 7Huang Z, Liu F. Diagnostic value of serum carbohydrate antigen 19-9 in pancreatic cancer: A meta-analysis [J]. Tumour Biol, 2014, 35 (8): 7459-7465.
  • 8Wang Z, Tian YP. Clinical value of serum tumor markers CA19-9, CA125 and CA72-4 in the diagnosis of pancreatic carcinoma [J]. Mol Clin Oncol, 2014, 2 (2): 265-268.
  • 9ChenJ, Wu W, Zhen C, et al. Expression and clinical significance of complement C3, complement C4bl and apolipoprotein E in pancreatic cancer [J]. Oncol Lett, 2013,6(1):43-48.
  • 10Fiorenza AM, Branchi A, Sommariva D. Serum lipoprotein profile in patients with cancer. A comparison with non-cancer subiects [J]. Int J Clin Lab Res, 2000, 30 (3) 141-145.

引证文献2

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部